Sun Pharmaceutical Industries Ltd's share price has fallen by -3.57%, presenting both challenges and opportunities for investors. As of now, it's trading at 1655.80, and market participants are assessing the implications. The stock has a PE ratio of 37.6200, an ROE of 14.8407 and a debt to equity ratio of 0.0670.



.jpg)



